<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1646-2122</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Ortopedia e Traumatologia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Port. Ortop. Traum.]]></abbrev-journal-title>
<issn>1646-2122</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Ortopedia e Traumatologia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1646-21222015000300003</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Espondilodiscite piogénica em adultos: diagnóstico e tratamento]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[Noronha de]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arcangelo]]></surname>
<given-names><![CDATA[Joana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pedrosa]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Figueira]]></surname>
<given-names><![CDATA[Paulo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Centro Hospitalar de Lisboa Central, EPE.  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2015</year>
</pub-date>
<volume>23</volume>
<numero>3</numero>
<fpage>225</fpage>
<lpage>235</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1646-21222015000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1646-21222015000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1646-21222015000300003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Espondilodiscite corresponde a um processo infeccioso que atinge o disco intervertebral e corpos vertebrais contíguos, afectando regra geral dois corpos vertebrais e o disco intervertebral adjacente. As manifestações clinicas podem ser agudas ou subagudas, dependendo de factores como a patogenicidade do microrganismo envolvido, competência imunológica ou idade, atingindo sobretudo o segmento lombar da coluna vertebral. A baixa incidência, percurso insidioso e a elevada prevalência de lombalgia na população geral dificultam o diagnóstico precoce, exigindo assim maior grau de suspeição. Quanto à etiologia pode ser piogénica ou granulomatosa, sendo a via hematogénica a forma de disseminação mais comum. O diagnóstico baseia-se na conjugação das manifestações clínicas, exames laboratoriais e imagiológicos. O tratamento é, na maioria dos casos, conservador, reservando-se a abordagem cirúrgica para os casos refractários, com deficit neurológico, deformidade ou instabilidade progressivas. Os autores fazem uma revisão do tema de modo a fornecer linhas orientadoras para um diagnóstico precoce e elaboram um diagrama de diagnóstico e abordagem terapêutica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Spondylodiscitis is an infectious condition that affects the intervertebral disc and adjacent vertebral bodies, usually affecting two adjacent vertebral bodies and the intervertebral disc. The clinical manifestations may be acute or subacute, depending on factors such as the pathogenicity of the etiological agent, immune status or age, particularly reaching the lumbar segment of the spine. The low incidence, insidious course and the high prevalence of low back pain in the general population difficult early diagnosis, thereby requiring a higher degree of suspicion. Concerning the etiology, it can be pyogenic or granulomatous, and the hematogenous way the most common form of dissemination. The diagnosis is based on the combination of clinical manifestations, laboratory and imaging tests. Treatment is conservative, in most cases, with surgical approach for refractory cases, with neurological deficit, progressive deformity or instability. The authors review the topic in order to provide guidelines for early diagnosis and prepare a diagram diagnostic and therapeutic approach.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Espondilodiscite]]></kwd>
<kwd lng="pt"><![CDATA[infecção]]></kwd>
<kwd lng="pt"><![CDATA[adulto]]></kwd>
<kwd lng="pt"><![CDATA[diagnóstico]]></kwd>
<kwd lng="pt"><![CDATA[terapêutica]]></kwd>
<kwd lng="en"><![CDATA[Spondylodiscitis]]></kwd>
<kwd lng="en"><![CDATA[infection]]></kwd>
<kwd lng="en"><![CDATA[adult]]></kwd>
<kwd lng="en"><![CDATA[diagnosis]]></kwd>
<kwd lng="en"><![CDATA[therapeutics]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><b><font face="Verdana" size="2">ARTIGO DE REVISÃO</font></b></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="4">Espondilodiscite piogénica em adultos - diagnóstico e tratamento </font></b></p>    <p>&nbsp;</p>    <p><font face="Verdana" size="2"><b>Jorge Costa<sup>I</sup></b>; <b>Noronha de Andrade<sup>I</sup></b>; <b>Joana Arcangelo<sup>I</sup></b>; <b>Carlos Pedrosa<sup>I</sup></b>; <b>Paulo Figueira<sup>I</sup></b></font></p>    <p><font face="Verdana" size="2">I. Centro Hospitalar de Lisboa Central, EPE. Portugal. Portugal.<br /></font></p>    <p>&nbsp;</p>    <p><font face="Verdana" size="2"><a name="topc"></a><a href="#c">Endereço para correspondência</a></font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">RESUMO</font></b></p><font face="verdana" size="2">    ]]></body>
<body><![CDATA[<p>Espondilodiscite corresponde a um processo infeccioso que atinge o disco intervertebral e corpos vertebrais cont&iacute;guos, afectando regra geral dois corpos vertebrais e o disco intervertebral adjacente. As manifesta&ccedil;&otilde;es clinicas podem ser agudas ou subagudas, dependendo de factores como a patogenicidade do microrganismo envolvido, compet&ecirc;ncia imunol&oacute;gica ou idade, atingindo sobretudo o segmento lombar da coluna vertebral. A baixa incid&ecirc;ncia, percurso insidioso e a elevada preval&ecirc;ncia de lombalgia na popula&ccedil;&atilde;o geral dificultam o diagn&oacute;stico precoce, exigindo assim maior grau de suspei&ccedil;&atilde;o. Quanto &agrave; etiologia pode ser piog&eacute;nica ou granulomatosa, sendo a via hematog&eacute;nica a forma de dissemina&ccedil;&atilde;o mais comum. O diagn&oacute;stico baseia-se na conjuga&ccedil;&atilde;o das manifesta&ccedil;&otilde;es cl&iacute;nicas, exames laboratoriais e imagiol&oacute;gicos. O tratamento &eacute;, na maioria dos casos, conservador, reservando-se a abordagem cir&uacute;rgica para os casos refract&aacute;rios, com deficit neurol&oacute;gico, deformidade ou instabilidade progressivas. Os autores fazem uma revis&atilde;o do tema de modo a fornecer linhas orientadoras para um diagn&oacute;stico precoce e elaboram um diagrama de diagn&oacute;stico e abordagem terap&ecirc;utica.</p></font>    <p><font face="verdana" size="2"><b>Palavras chave</b>: Espondilodiscite, infecção, adulto, diagnóstico, terapêutica. </font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">ABSTRACT</font></b></p><font face="verdana" size="2">    <p>Spondylodiscitis is an infectious condition that affects the intervertebral disc and adjacent vertebral bodies, usually affecting two adjacent vertebral bodies and the intervertebral disc. The clinical manifestations may be acute or subacute, depending on factors such as the pathogenicity of the etiological agent, immune status or age, particularly reaching the lumbar segment of the spine. The low incidence, insidious course and the high prevalence of low back pain in the general population difficult early diagnosis, thereby requiring a higher degree of suspicion.</p>     <p>Concerning the etiology, it can be pyogenic or granulomatous, and the hematogenous way the most common form of dissemination. The diagnosis is based on the combination of clinical manifestations, laboratory and imaging tests. Treatment is conservative, in most cases, with surgical approach for refractory cases, with neurological deficit, progressive deformity or instability. The authors review the topic in order to provide guidelines for early diagnosis and prepare a diagram diagnostic and therapeutic approach.</p></font>    <p><font face="verdana" size="2"><b>Key words</b>: Spondylodiscitis, infection, adult, diagnosis, therapeutics. </font></p>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">EPIDEMIOLOGIA</font></b></p><font face="verdana" size="2">    <p>Espondilodiscite &eacute; um termo global que inclui osteomielite vertebral, espondilite e discite, correspondendo a cerca de 3 a 5% de todos os casos de osteomielite<sup>1-5</sup>. Ocorre em cerca de 0.5 a 2.5 casos por cada 100 000 habitantes/ano<sup>6</sup>, sendo o sexo masculino mais afectado numa propor&ccedil;&atilde;o de 3:14. Apresenta um pico de incid&ecirc;ncia bimodal, o primeiro pico at&eacute; aos 20 anos e o segundo entre os 50 e 70 anos<sup>4,7</sup>. Entre 41 e 75% das infec&ccedil;&otilde;es piog&eacute;nicas ocorrem em adultos acima de 50 anos e predominam na coluna lombar<sup>7,8</sup>. A incid&ecirc;ncia, embora baixa, tem vindo a aumentar devido a factores como o uso crescente de drogas endovenosas, cirurgia raquidiana, envelhecimento da popula&ccedil;&atilde;o e comorbilidades associadas<sup>1,4,5,7,12</sup>.</p></font>    ]]></body>
<body><![CDATA[<p>&nbsp;</p>    <p><b><font face="Verdana" size="2">ETIOPATOGÉNESE</font></b></p><font face="verdana" size="2">    <p>Existem dois grandes grupos etiol&oacute;gicos de espondilodiscite na popula&ccedil;&atilde;o adulta: a espondilodiscite piog&eacute;nica, cujo agente etiol&oacute;gico mais frequente &eacute; o <em>Staphylococcus Aureus</em><sup>10-13</sup>, e a granulomatosa, causada por <em>Mycobacterium Tuberculosis</em> e/ou <em>Brucella Mellitensis</em>, ambas end&eacute;micas em Portugal e, por este motivo, referidas nesta revis&atilde;o<sup>11,12</sup>. Existem tr&ecirc;s vias de dissemina&ccedil;&atilde;o: via hematog&eacute;nica, por inocula&ccedil;&atilde;o direta e por contiguidade<sup>1,2,5,10,12,14</sup>. A exist&ecirc;ncia de anastomoses intra&oacute;sseas de <em>low-flow</em> vascular e a inexist&ecirc;ncia de uma rede vascular ao n&iacute;vel do disco intervertebral no adulto, permitem a dissemina&ccedil;&atilde;o arterial (mais comum) ou venosa de focos s&eacute;pticos para a coluna, levando assim &agrave; propaga&ccedil;&atilde;o bacteriana para os corpos vertebrais adjacentes, a partir do disco envolvido<sup>1,10,12</sup>. A manuten&ccedil;&atilde;o da infec&ccedil;&atilde;o pode levar ao colapso dos corpos vertebrais, com compress&atilde;o medular, bem como estender-se aos tecidos moles adjacentes, atrav&eacute;s de abcessos paravertebrais ou, nos casos de espondilodiscite lombar, de abcessos do componente psoas do m&uacute;sculo psoas il&iacute;aco, constituindo estes, por vezes, a primeira manifesta&ccedil;&atilde;o radiol&oacute;gica da infec&ccedil;&atilde;o<sup>1</sup>. Em cerca de 17% dos casos est&aacute; referido o aparecimento de abcessos epidurais com risco de risco de invas&atilde;o do canal medular e consequente mielopatia, forma&ccedil;&atilde;o de abcessos subdurais e meningite<sup>10</sup>. A espondilodiscite piog&eacute;nica afecta principalmente o segmento lombar da coluna vertebral (60%), seguindo-se o segmento tor&aacute;cico (30%) e, por &uacute;ltimo, o cervical (10%)<sup>1,6,12,17</sup>. A espondilodiscite tuberculosa, por seu lado, localiza-se com maior frequ&ecirc;ncia a n&iacute;vel do segmento tor&aacute;cico, envolvendo habitualmente mais do que dois segmentos vertebrais, cont&iacute;guos ou n&atilde;o, bem como os elementos vertebrais posteriores, factores que a diferenciam das restantes etiologias (<a href="/img/revistas/rpot/v23n3/23n3a03t1.jpg">Tabela 1</a>)<sup>1,15</sup>.</p>    
<p>&nbsp;</p>    <p>    <center><a href="/img/revistas/rpot/v23n3/23n3a03t1.jpg">Tabela 1</a></center></p>    
<p>&nbsp;</p>
    <p>S&atilde;o tr&ecirc;s as grandes vias de transmiss&atilde;o de espondilodiscite piog&eacute;nica. A via hematog&eacute;nica &eacute; a mais comum e corresponde a cerca de 70% dos casos; a inocula&ccedil;&atilde;o direta acomete cerca de 25%; a propaga&ccedil;&atilde;o por contiguidade, regra geral, deve-se a abcessos retrofar&iacute;ngeos ou retroperitoneais<sup>2,5,16</sup>.</p>
    <p>Existem m&uacute;ltiplos fatores de risco que se associam ao seu aparecimento (<a name="topt2"></a><a href="#t2">Tabela 2</a>)<sup>2,7,12,16</sup>. A maioria dos doentes apresenta pelo menos 1 fator de risco; no entanto, caso n&atilde;o se verifique esta condi&ccedil;&atilde;o, deve ser considerado um diagn&oacute;stico alternativo.</p>    <p>&nbsp;</p><a name="t2"></a>     ]]></body>
<body><![CDATA[<p>    <center><img src="/img/revistas/rpot/v23n3/23n3a03t2.jpg" width="391" height="524" border="0" /></center></p>    
<p>&nbsp;</p>
    <p>A diabetes <em>mellitus</em> &eacute; o fator de risco mais comum no desenvolvimento da espondilodiscite piog&eacute;nica<sup>1,6,16</sup>, particularmente nos casos de hemoglobina glicosilada superior a 8.5, seguida das infe&ccedil;&otilde;es do tracto urin&aacute;rio ou respirat&oacute;rio<sup>14</sup>, tendo-se observado nos &uacute;ltimos anos um aumento das infec&ccedil;&otilde;es por microrganismos gram negativos, nomeadamente por <em>Escherichia coli</em><sup>5</sup>. O uso de drogas endovenosas, bem como a exist&ecirc;ncia de feridas contaminadas, deve alertar para a infec&ccedil;&atilde;o por <em>Pseudomonas aeruginosa</em><sup>12,16</sup>. A infec&ccedil;&atilde;o por <em>Salmonella</em> &eacute; patognom&oacute;nica de <em>Drepanocitose</em> e deve ser pesquisada em doentes provenientes da africa sub-sahariana ou de pa&iacute;ses do Mediterr&acirc;neo como Turquia, Gr&eacute;cia ou It&aacute;lia<sup>1</sup>.</p>
    <p>Os agentes mais comuns de espondilodiscite piog&eacute;nica e granulomatosa incluem o <em>Staphylococcus aureus</em> e a <em>Brucella Mellitensis</em>, respectivamente (<a name="topt3"></a><a href="#t3">Tabela 3</a>)<sup>1</sup>.</p>    <p>&nbsp;</p><a name="t3"></a>     <p>    <center><img src="/img/revistas/rpot/v23n3/23n3a03t3.jpg" width="389" height="368" border="0" /></center></p>    
<p>&nbsp;</p></font>    <p>&nbsp;</p>    ]]></body>
<body><![CDATA[<p><b><font face="Verdana" size="2">MANIFESTAÇÕES CLÍNICAS</font></b></p><font face="verdana" size="2">    <p>A sintomatologia da espondilodiscite piog&eacute;nica &eacute; inespec&iacute;fica e a sua apresenta&ccedil;&atilde;o muito dependente da localiza&ccedil;&atilde;o anat&oacute;mica, extens&atilde;o da doen&ccedil;a e compet&ecirc;ncia imunol&oacute;gica do doente, sendo necess&aacute;rio um &iacute;ndice de suspei&ccedil;&atilde;o elevado para o seu diagnostico<sup>1,3-5,14,17</sup>. O in&iacute;cio &eacute; insidioso, com raquialgia de agravamento progressivo, podendo o doente recorrer m&uacute;ltiplas vezes ao servi&ccedil;o de urg&ecirc;ncia<sup>1,6,12,17</sup>. Num estadio mais avan&ccedil;ado da doen&ccedil;a, a raquialgia pode ser muito marcada, com dor intensa &agrave; palpa&ccedil;&atilde;o das ap&oacute;fises espinhosas e musculatura paravertebral, n&atilde;o cedendo &agrave; terap&ecirc;utica analg&eacute;sica. O agravamento das queixas no per&iacute;odo noturno &eacute; muito frequente, devendo assim alertar para um quadro infeccioso ou neopl&aacute;sico<sup>18</sup>. A raquialgia pode ser acompanhada de irradia&ccedil;&atilde;o para a regi&atilde;o tor&aacute;cica ou abdominal<sup>5,14</sup>. A ocorr&ecirc;ncia de febre n&atilde;o &eacute; comum, existindo apenas em cerca de 15 a 50% dos doentes<sup>4,5,14</sup>. Um <em>deficit</em> neurol&oacute;gico pode estar presente em cerca de 10 a 20% dos doentes; &eacute; causado pelo envolvimento infeccioso direto dos elementos neurais, vasculite induzida por abcesso, compress&atilde;o por colapso vertebral, trombose dos seios de drenagem ou compress&atilde;o medular por abcesso epidural<sup>5</sup>. Pode existir diminui&ccedil;&atilde;o da for&ccedil;a muscular, altera&ccedil;&otilde;es sensitivas, radiculopatia, mielopatia, altera&ccedil;&otilde;es esfincterianas ou paraplegia (se compress&atilde;o por abcesso vertebral ou colapso vertebral)<sup>7,10</sup>. Em cerca de 20% dos doentes com espondilodiscite observa-se a ocorr&ecirc;ncia de abcessos epidurais, que correspondem a uma cole&ccedil;&atilde;o purulenta entre a duram&aacute;ter e o tecido adiposo circundante, ocorrendo habitualmente nos casos n&atilde;o tratados ou tardiamente diagnosticados<sup>14</sup>. Os fatores de risco s&atilde;o similares aos da espondilodiscite; a localiza&ccedil;&atilde;o mais comum corresponde &agrave; transi&ccedil;&atilde;o dorsolombar, 50% dos doentes apresentam sinais neurol&oacute;gicos e, destes, 5 a 20% paraplegia permanente por compress&atilde;o direta ou an&oacute;xia medular. A meningite &eacute; outra das complica&ccedil;&otilde;es poss&iacute;veis e ocorre nos casos de propaga&ccedil;&atilde;o da infe&ccedil;&atilde;o atrav&eacute;s do abcesso epidural<sup>1,5</sup>.</p>
    <p>A contractura em flex&atilde;o ou dor &agrave; extens&atilde;o da anca deve alertar para a exist&ecirc;ncia de um abcesso da componente psoas do m&uacute;sculo psoas il&iacute;aco; nos casos de abcesso cervical pode haver torcicolo ou disfagia<sup>10</sup>.</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">DIAGNÓSTICO</font></b></p><font face="verdana" size="2">    <p>O diagn&oacute;stico da espondilodiscite &eacute; estabelecido com base nas manifesta&ccedil;&otilde;es cl&iacute;nicas, altera&ccedil;&otilde;es laboratoriais e imagiol&oacute;gicas. Se diagnosticada atempadamente, tem uma elevada taxa de sucesso, de aproximadamente 80%<sup>22</sup>; no entanto, devido &agrave; sintomatologia fruste na sua fase inicial, alta preval&ecirc;ncia de lombalgia na popula&ccedil;&atilde;o geral ou &agrave; pr&oacute;pria raridade da doen&ccedil;a, o seu diagn&oacute;stico leva em m&eacute;dia 11 a 59 dias at&eacute; ser estabelecido, ap&oacute;s o in&iacute;cio dos sintomas, facto que pode levar a consequ&ecirc;ncias t&atilde;o devastadoras como incontin&ecirc;ncia esfincteriana ou paraplegia<sup>5,14,18-20</sup>. A avalia&ccedil;&atilde;o inclui uma anamnese cuidada, exame neurol&oacute;gico completo, avalia&ccedil;&atilde;o laboratorial e imagiol&oacute;gica, e biopsia. A avalia&ccedil;&atilde;o laboratorial deve incluir obrigatoriamente hemograma, prote&iacute;na C reativa e velocidade de sedimenta&ccedil;&atilde;o<sup>1,2</sup>. As hemoculturas s&atilde;o positivas apenas em 33 a 66% dos casos<sup>1,14,21</sup>; devem ser efetuadas antes do in&iacute;cio da antibioterapia, incluindo a pesquisa de aer&oacute;bios, anaer&oacute;bios, fungos e bacilos acido-&aacute;lcool resistentes<sup>2,7</sup>. A identifica&ccedil;&atilde;o do agente bacteriano &eacute; mandat&aacute;ria para o tratamento dirigido da espondilodiscite<sup>2,3</sup>. A biopsia &oacute;ssea guiada por tomografia computorizada (TC) est&aacute; reservada aos casos em que h&aacute; evid&ecirc;ncia imagiol&oacute;gica de doen&ccedil;a mas com exames bacteriol&oacute;gicos persistentemente negativos<sup>1,2</sup> ou casos sem indica&ccedil;&atilde;o cir&uacute;rgica imediata, podendo esta tamb&eacute;m ser realizada por via aberta (via anterior, costotransversectomia, ou transpedicular)<sup>1,2,10,17,21,22</sup>.</p>
    <p>Os exames imagiol&oacute;gicos permitem identificar o local de infe&ccedil;&atilde;o, nomeadamente corpo vertebral, disco, espa&ccedil;o epidural, tecidos moles paravertebrais ou elementos posteriores. Radiologicamente, ao fim dos primeiros dias de infe&ccedil;&atilde;o, j&aacute; existe edema de tecidos moles paravertebrais (por exemplo, perda da sombra do psoas). Ap&oacute;s 7 a 14 dias, observa-se destrui&ccedil;&atilde;o do disco (a destrui&ccedil;&atilde;o do disco &eacute; tardia na tuberculose e at&iacute;pica nas neoplasias) com diminui&ccedil;&atilde;o do espa&ccedil;o intervertebral. Ap&oacute;s 4 a 8 semanas, verifica-se a eros&atilde;o dos pratos vertebrais, com esclerose e osteopenia locais, e aumento do risco de fractura ou colapso vertebral<sup>14</sup>.</p>
    <p>A resson&acirc;ncia magn&eacute;tica (RM) com gadol&iacute;nio &eacute; o exame <em>gold standard</em> para a identifica&ccedil;&atilde;o da espondilodiscite e consequente diagn&oacute;stico diferencial com neoplasia, les&otilde;es ocupando espa&ccedil;o epidurais, massas subdurais, envolvimento men&iacute;ngeo ou medular<sup>1,14</sup>. &Eacute; caracter&iacute;stico a redu&ccedil;&atilde;o de sinal nas vertebras adjacentes (T1) e aumento ao n&iacute;vel do disco (T2 e STIR); tem uma sensibilidade de 93% e especificidade de 96%<sup>1,12,14</sup>. O gadol&iacute;nio permite fazer a diferencia&ccedil;&atilde;o entre o l&iacute;quido cefalorraquidiano e o sangue.</p>
    <p>Nos casos em que n&atilde;o &eacute; poss&iacute;vel realizar RM, deve-se optar por cintigrafia com tecn&eacute;cio e g&aacute;lio ou TC com contraste, nos casos de les&atilde;o &oacute;ssea associada ou exist&ecirc;ncia de material de osteoss&iacute;ntese. A TC apresenta pouca sensibilidade para o diagn&oacute;stico de abcesso epidurais ou paravertebrais (<a name="topt4"></a><a href="#t4">Tabela 4</a>)<sup>18</sup>.</p>    <p>&nbsp;</p><a name="t4"></a>     ]]></body>
<body><![CDATA[<p>    <center><img src="/img/revistas/rpot/v23n3/23n3a03t4.jpg" width="393" height="522" border="0" /></center></p>    
<p>&nbsp;</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">TRATAMENTO</font></b></p><font face="verdana" size="2">    <p>O tratamento da espondilodiscite pode ser conservador ou cir&uacute;rgico. O tratamento conservador est&aacute; indicado nos casos de infe&ccedil;&atilde;o recente, inexist&ecirc;ncia de <em>deficit</em> neurol&oacute;gico ou comorbilidades que impe&ccedil;am uma cirurgia (<a href="/img/revistas/rpot/v23n3/23n3a03t5.jpg">Tabela 5</a>)<sup>3</sup>. A antibioterapia dirigida deve ser iniciada ap&oacute;s identifica&ccedil;&atilde;o do agente por hemocultura ou biopsia, consistindo em 4 a 6 semanas de tratamento endovenoso at&eacute; melhoria dos sintomas; deve posteriormente ser convertida para a via oral e assim mantida por um per&iacute;odo m&iacute;nimo de 6 a 12 semanas, sob controlo anal&iacute;tico dos par&acirc;metros de infec&ccedil;&atilde;o (<a name="topt6"></a><a href="#t6">Tabela 6</a>)<sup>3,17,18,21</sup>. O tratamento conservador leva &agrave; resolu&ccedil;&atilde;o em cerca de 80% dos casos, em associa&ccedil;&atilde;o com repouso no leito e imobiliza&ccedil;&atilde;o com ort&oacute;tese, para conforto do doente ou preven&ccedil;&atilde;o da deformidade. Os casos de espondilodiscite cervical podem ter indica&ccedil;&atilde;o para ort&oacute;tese cervical, r&iacute;gida ou Halo<sup>3,21-23</sup>.</p>    
<p>&nbsp;</p>    <p>    <center><a href="/img/revistas/rpot/v23n3/23n3a03t5.jpg">Tabela 5</a></center></p>    
<p>&nbsp;</p><a name="t6"></a>     ]]></body>
<body><![CDATA[<p>    <center><img src="/img/revistas/rpot/v23n3/23n3a03t6.jpg" width="390" height="375" border="0" /></center></p>    
<p>&nbsp;</p>
    <p>O tratamento cir&uacute;rgico tem como objectivos erradicar a infe&ccedil;&atilde;o, prevenir ou melhorar o <em>deficit</em> neurol&oacute;gico e manter a estabilidade da coluna vertebral, assentando nos pressupostos da descompress&atilde;o e estabiliza&ccedil;&atilde;o; deve estar reservado aos casos de apresenta&ccedil;&atilde;o tardia, persist&ecirc;ncia da infe&ccedil;&atilde;o ou abcesso sem resposta &agrave; antibioterapia institu&iacute;da, deformidade progressiva e instabilidade (atingimento de mais de uma coluna), presen&ccedil;a ou progress&atilde;o de <em>deficit</em> neurol&oacute;gico ou abcesso epidural com atingimento neurol&oacute;gico<sup>2,3,14,16,17,21,24</sup>. O desbridamento cir&uacute;rgico, a artrodese com espa&ccedil;ador de tit&acirc;nio ou o enxerto &oacute;sseo por via anterior constituem o <em>gold standard</em> cir&uacute;rgico da espondilodiscite piog&eacute;nica<sup>3,6,14,21,24</sup>.</p>
    <p>A via anterior permite uma melhor exposi&ccedil;&atilde;o de abcessos dos m&uacute;sculos psoas e paravertebrais e, consequentemente, melhor desbridamento cir&uacute;rgico, devendo ser acompanhada de instrumenta&ccedil;&atilde;o posterior na presen&ccedil;a de colapso ou envolvimento de mais de uma coluna (teoria das tr&ecirc;s colunas de Dennis), deformidade cif&oacute;tica grave, abordagem anterior a v&aacute;rios n&iacute;veis, instabilidade segmentar (espondilolistese ou escoliose degenerativa) ou instabilidade cir&uacute;rgica (laminectomia <em>wide-to-wide</em> e/ou remo&ccedil;&atilde;o de mais de 50% das facetas)<sup>14,24,25</sup>. O desbridamento e descompress&atilde;o posterior (laminectomia), com ou sem instrumenta&ccedil;&atilde;o, pode estar indicado na presen&ccedil;a de infe&ccedil;&atilde;o posterior ou abscesso epidural isolado<sup>16,24</sup>. Tamb&eacute;m a exist&ecirc;ncia de um abcesso vertebral localizado apenas na coluna anterior, envolvendo disco e corpos vertebrais, pode ser tratado atrav&eacute;s de desbridamento anterior isolado sem ser necess&aacute;rio recorrer a instrumenta&ccedil;&atilde;o<sup>14</sup>. O m&eacute;todo mini-invasivo (MISS) tem indica&ccedil;&atilde;o nos abcessos de menor extens&atilde;o envolvendo, regra geral, apenas um disco e 2 corpos vertebrais<sup>16</sup>.</p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">CONCLUSÃO</font></b></p><font face="verdana" size="2">    <p>A espondilodiscite &eacute; uma entidade rara, mas a sua incid&ecirc;ncia tem vindo a aumentar devido ao envelhecimento da popula&ccedil;&atilde;o, aumento da popula&ccedil;&atilde;o imunocomprometida, uso de drogas endovenosas e ao aumento de procedimentos invasivos da coluna vertebral, associada ao desenvolvimento dos meios complementares de diagn&oacute;stico<sup>1,4,5,7,12</sup>. &Eacute; necess&aacute;rio um elevado &iacute;ndice de suspei&ccedil;&atilde;o, devendo ter-se em aten&ccedil;&atilde;o os casos de lombalgia prolongada, sem resposta &agrave; terap&ecirc;utica institu&iacute;da e sem evid&ecirc;ncia de outra patologia.</p>
    <p>O <em>Staphylococcus aureus</em> constitui o agente etiol&oacute;gico mais comummente isolado<sup>10-13</sup>. O diagn&oacute;stico &eacute;, muitas vezes, um verdadeiro desafio para o cl&iacute;nico, mas, se atempado, garante bons resultados a longo prazo<sup>5,14,18,19</sup>. Imagiologicamente, a diminui&ccedil;&atilde;o do espa&ccedil;o intervertebral com eros&atilde;o do prato do corpo vertebral &eacute; o achado mais precoce, seguido da destrui&ccedil;&atilde;o progressiva do corpo vertebral<sup>14</sup>. A RM mostrou-se extremamente valiosa na detec&ccedil;&atilde;o de compress&atilde;o medular em doentes com <em>deficits</em> neurol&oacute;gicos<sup>21</sup>. O diagn&oacute;stico cultural &eacute; tamb&eacute;m essencial para permitir terap&ecirc;utica antibi&oacute;tica dirigida<sup>2,3</sup>. Deve incluir, pelo menos, 4 a 6 semanas de antibioterapia endovenosa, com imobiliza&ccedil;&atilde;o para controlo da dor<sup>3,21</sup>. A abordagem cir&uacute;rgica est&aacute; indicada em todos os doentes com <em>deficit</em> neurol&oacute;gico. A cirurgia tem um papel importante no al&iacute;vio da dor, na correc&ccedil;&atilde;o das deformidades e do comprometimento neurol&oacute;gico, e na restaura&ccedil;&atilde;o da fun&ccedil;&atilde;o deteriorada pela patologia<sup>2,3,14,16,17,21,24</sup>.</p>
    <p>O desenvolvimento de novos m&eacute;todos de diagn&oacute;stico, a evolu&ccedil;&atilde;o da terap&ecirc;utica antimicrobiana e o avan&ccedil;o das t&eacute;cnicas cir&uacute;rgicas s&atilde;o os principais respons&aacute;veis pela transforma&ccedil;&atilde;o na perspectiva para os doentes com esta condi&ccedil;&atilde;o; no entanto, apesar de atualmente a mortalidade ser rara, continua a associar-se a uma significativa morbilidade.</p>
    ]]></body>
<body><![CDATA[<p>Na literatura cient&iacute;fica s&atilde;o escassos os estudos randomizados sobre espondilodiscite e os existentes s&atilde;o muito heterog&eacute;neos para permitir uma compara&ccedil;&atilde;o entre eles. Ensaios cl&iacute;nicos randomizados s&atilde;o necess&aacute;rios para avaliar a dura&ccedil;&atilde;o &oacute;ptima do tratamento, a via de administra&ccedil;&atilde;o, bem como o papel da terap&ecirc;utica combinada e dos f&aacute;rmacos mais recentes.<br /><br /></p></font>    <p>&nbsp;</p>    <p><b><font face="Verdana" size="2">REFERÊNCIAS BIBLIOGRÁFICAS</font></b></p>    <!-- ref --><p><font face="verdana" size="2">1. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother. 2010; 65 (3): 11-24</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308602&pid=S1646-2122201500030000300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">2. Sobottke R. Current diagnosis and treatment of spondylodiscitis. Dtsch Arztebl Int. 2008; 105: 181-187</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308603&pid=S1646-2122201500030000300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">3. Zarghooni K. Treatment of spondylodiscitis. International Orthopaedics (SICOT). 2008; 36: 405-411</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308604&pid=S1646-2122201500030000300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">4. Bettini N. Evaluation of conservative treatment of non specific spondylodiscitis. Eur Spine J. 2009; 18 (1): 143-150</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308605&pid=S1646-2122201500030000300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">5. Duarte RM, Vaccaro AR. Spinal infection: state of the art and management algorithm. Eur Spine J. 2013; 22: 2787-2799</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308606&pid=S1646-2122201500030000300005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">6. Herrero C. Infectious Spondylodiscitis: Has there been any evolution in the diagnostic and treatment outcomes? . Coluna/Columna. 2014; 13 (4): 295-297</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308607&pid=S1646-2122201500030000300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">7. Espondilodiscites sépticas: Diagnóstico e tratamento. Arq. Neuro-Psiquiatr. 2003 Sep; 61 (3B)</font></p>    ]]></body>
<body><![CDATA[<!-- ref --><p><font face="verdana" size="2">8. Mylona E. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009; 39: 10-17</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308609&pid=S1646-2122201500030000300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">9. Meredith DS. Postoperative infection of the lumbar spine: presentation and management. International Orthopaedics (SICOT). 2012; 30: 439-444</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308610&pid=S1646-2122201500030000300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">10. Camillo FX. Campbell&#39;s Operative Orthopaedics. In Canale ST, Beaty J. , editors. Infections of the spine. . Mosby, USA: 12th Edition; 2012. p. 1965-1991.</font></p>    <p><font face="verdana" size="2">11. Lebre A. Espondilodiscite Brucélica: Casuística dos Últimos 25 Anos. Acta Med Port. 2014 Mar; 27 (2): 204-210</font></p>    <!-- ref --><p><font face="verdana" size="2">12. Faria R. Espondilodiscite. Que etiologia?. Acta Med Port. 2011; 24 (6): 1059-1064</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308613&pid=S1646-2122201500030000300012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">13. Capeli J. Espondilodiscite infecciosa: o estudo de quarenta e um casos. Acta Reum Port. 2007; 32: 255-262</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308614&pid=S1646-2122201500030000300013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">14. Levin R, Bono CM, Garfin SR. Vertebral Discitis and Osteomyelitis. In AR Vaccaro, editors. Core Knowledge in Orthopaedics: Spine. Philadelphia: Mosby; 2005. p. 212-225.</font></p>    <!-- ref --><p><font face="verdana" size="2">15. Chang MC. Tuberculous spondylitis and pyogenic spondylitis: comparative magnetic resonance imaging features. Spine. 2006; 31: 782-788</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308616&pid=S1646-2122201500030000300015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">16. Guerado E, Cerván AM. Surgical treatment of spondylodiscitis. An update. International Orthopaedics (SICOT). 2012; 36: 413-420</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308617&pid=S1646-2122201500030000300016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p><font face="verdana" size="2">17. Mylona E. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009 Aug; 39 (1): 10-17</font></p>    ]]></body>
<body><![CDATA[<!-- ref --><p><font face="verdana" size="2">18. Chenoweth CE. Vertebral Osteomyelitis, Discitis, and Spinal Epidural Abscess in Adults. [Guidelines for Clinical Care Inpatient]. Faculty Group Practice Quality Management Program. University of Michigan; 2013.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308619&pid=S1646-2122201500030000300018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> </font></p>    <p><font face="verdana" size="2">19. Consciência JG, Pinto R, Saldanha T. Infections of the Spine. In Bentley G, editors. European Surgical Orthopaedics and Traumatology - The EFORT Textbook. 15th EFORT. London: Springer; 2014. p. 801-812.</font></p>    <p><font face="verdana" size="2">20. Tsiodras S, Falagas ME. Clinical assessment and medical treatment of spine infections. Clin Orthop Relat Res. 2006 Mar; 444: 38-50</font></p>    <p><font face="verdana" size="2">21. Pola E. Medical and surgical treatment of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci. 2012 Apr; 16 (2): 35-49</font></p>    <!-- ref --><p><font face="verdana" size="2">22. Livorsi DJ. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA era. J Infect. 2008; 57: 128-131</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308624&pid=S1646-2122201500030000300022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">23. Gerometta A, Bittan F, Olaverri JCR. Postoperative spondilodiscitis. International Orthopaedics (SICOT). 2012; 36: 433-438</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308625&pid=S1646-2122201500030000300023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">24. Vcelák J, Chomiak J, Toth L. Surgical treatment of lumbar spondylodiscitis: a comparison of two methods. International Orthopaedics (SICOT). 2014; 38: 1425-1434</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308626&pid=S1646-2122201500030000300024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">25. Chen WH, Jiang LS, Dai LY. Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation. Eur Spine J. 2007; 16: 1307-1316</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308627&pid=S1646-2122201500030000300025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p><font face="verdana" size="2">26. Hadjipavlou AG. Hematogenous pyogenic spinal infections and their surgical management. Spine. 2000; 25: 1668</font>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1308628&pid=S1646-2122201500030000300026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>    <p><b><font face="Verdana" size="2">Conflito de interesse: </font></b></p><font face="verdana" size="2">    <p>Nada a declarar</p></font>    <p>&nbsp;</p><a name="c"></a>    <p><b><font face="Verdana" size="2"><a href="#topc">Endereço para correspondência</a></font></b></p>    <p><font face="Verdana" size="2">Jorge Homero Moura Guedes de Andrade e Costa    <br>Hospital Curry Cabral    <br>Rua da Beneficência nº 8    <br>1069-166 Lisboa    <br>Telefone: 21 792 4200    ]]></body>
<body><![CDATA[<br><a href="mailto:jorgehomerocosta@hotmail.com">jorgehomerocosta@hotmail.com</a></font></p>    <p>&nbsp;</p>    <p><font face="verdana" size="2"><b>Data de Submissão: </b> 2015-08-10</font></p>    <p><font face="verdana" size="2"><b>Data de Revisão: </b> 2015-09-15</font></p>    <p><font face="verdana" size="2"><b>Data de Aceitação: </b> 2016-02-01</font></p>     ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gouliouris]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Aliyu]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Spondylodiscitis: update on diagnosis and management]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>2010</year>
<volume>65</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>11-24</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sobottke]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current diagnosis and treatment of spondylodiscitis]]></article-title>
<source><![CDATA[Dtsch Arztebl Int]]></source>
<year>2008</year>
<volume>105</volume>
<page-range>181-187</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarghooni]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Treatment of spondylodiscitis]]></article-title>
<source><![CDATA[International Orthopaedics (SICOT)]]></source>
<year>2008</year>
<volume>36</volume>
<page-range>405-411</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bettini]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evaluation of conservative treatment of non specific spondylodiscitis]]></article-title>
<source><![CDATA[Eur Spine J]]></source>
<year>2009</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>143-150</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Vaccaro]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Spinal infection: state of the art and management algorithm]]></article-title>
<source><![CDATA[Eur Spine J]]></source>
<year>2013</year>
<volume>22</volume>
<page-range>2787-2799</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infectious Spondylodiscitis: Has there been any evolution in the diagnostic and treatment outcomes?]]></article-title>
<source><![CDATA[Coluna/Columna]]></source>
<year>2014</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>295-297</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<article-title xml:lang="pt"><![CDATA[Espondilodiscites sépticas: Diagnóstico e tratamento]]></article-title>
<source><![CDATA[Arq. Neuro-Psiquiatr]]></source>
<year>09/2</year>
<month>00</month>
<day>3</day>
<volume>61</volume>
<numero>3B</numero>
<issue>3B</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mylona]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics]]></article-title>
<source><![CDATA[Semin Arthritis Rheum]]></source>
<year>2009</year>
<volume>39</volume>
<page-range>10-17</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meredith]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Postoperative infection of the lumbar spine: presentation and management]]></article-title>
<source><![CDATA[International Orthopaedics (SICOT)]]></source>
<year>2012</year>
<volume>30</volume>
<page-range>439-444</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camillo]]></surname>
<given-names><![CDATA[FX]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Campbell's Operative Orthopaedics]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Canale]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Beaty]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Infections of the spine.]]></source>
<year>2012</year>
<page-range>1965-1991</page-range><publisher-loc><![CDATA[Mosby ]]></publisher-loc>
<publisher-name><![CDATA[12th Edition]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lebre]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Espondilodiscite Brucélica: Casuística dos Últimos 25 Anos]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>03/2</year>
<month>01</month>
<day>4</day>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>204-210</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faria]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Espondilodiscite: Que etiologia?]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2011</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1059-1064</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capeli]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Espondilodiscite infecciosa: o estudo de quarenta e um casos]]></article-title>
<source><![CDATA[Acta Reum Port]]></source>
<year>2007</year>
<volume>32</volume>
<page-range>255-262</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bono]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Garfin]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vertebral Discitis and Osteomyelitis]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[AR]]></surname>
<given-names><![CDATA[Vaccaro]]></given-names>
</name>
</person-group>
<source><![CDATA[Core Knowledge in Orthopaedics: Spine]]></source>
<year>2005</year>
<page-range>212-225</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Mosby]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tuberculous spondylitis and pyogenic spondylitis: comparative magnetic resonance imaging features]]></article-title>
<source><![CDATA[Spine]]></source>
<year>2006</year>
<volume>31</volume>
<page-range>782-788</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cerván]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Surgical treatment of spondylodiscitis: An update]]></article-title>
<source><![CDATA[International Orthopaedics (SICOT)]]></source>
<year>2012</year>
<volume>36</volume>
<page-range>413-420</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mylona]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics]]></article-title>
<source><![CDATA[Semin Arthritis Rheum]]></source>
<year>08/2</year>
<month>00</month>
<day>9</day>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-17</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chenoweth]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<source><![CDATA[Vertebral Osteomyelitis, Discitis, and Spinal Epidural Abscess in Adults]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Consciência]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Saldanha]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infections of the Spine]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bentley]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[European Surgical Orthopaedics and Traumatology: The EFORT Textbook 15th EFORT]]></source>
<year>2014</year>
<page-range>801-812</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsiodras]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Falagas]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical assessment and medical treatment of spine infections]]></article-title>
<source><![CDATA[Clin Orthop Relat Res]]></source>
<year>03/2</year>
<month>00</month>
<day>6</day>
<volume>444</volume>
<page-range>38-50</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pola]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Medical and surgical treatment of pyogenic spondylodiscitis]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>04/2</year>
<month>01</month>
<day>2</day>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>35-49</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Livorsi]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA era]]></article-title>
<source><![CDATA[J Infect]]></source>
<year>2008</year>
<volume>57</volume>
<page-range>128-131</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gerometta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bittan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Olaverri]]></surname>
<given-names><![CDATA[JCR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Postoperative spondilodiscitis]]></article-title>
<source><![CDATA[International Orthopaedics (SICOT)]]></source>
<year>2012</year>
<volume>36</volume>
<page-range>433-438</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vcelák]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chomiak]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Toth]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Surgical treatment of lumbar spondylodiscitis: a comparison of two methods]]></article-title>
<source><![CDATA[International Orthopaedics (SICOT)]]></source>
<year>2014</year>
<volume>38</volume>
<page-range>1425-1434</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Dai]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation]]></article-title>
<source><![CDATA[Eur Spine J]]></source>
<year>2007</year>
<volume>16</volume>
<page-range>1307-1316</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hadjipavlou]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hematogenous pyogenic spinal infections and their surgical management]]></article-title>
<source><![CDATA[Spine]]></source>
<year>2000</year>
<volume>25</volume>
<page-range>1668</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
